Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner
Neuroinflammation that is caused by microglia, the main immune cells of the brain, contributes to neurodegenerative diseases. Psychedelics, including psilocybin and lysergic acid diethylamide (LSD), possess certain anti-inflammatory properties and, therefore, should be considered as drug candidates...
Saved in:
| Published in: | Molecules (Basel, Switzerland) Vol. 29; no. 21; p. 5084 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Basel
MDPI AG
28-10-2024
MDPI |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Neuroinflammation that is caused by microglia, the main immune cells of the brain, contributes to neurodegenerative diseases. Psychedelics, including psilocybin and lysergic acid diethylamide (LSD), possess certain anti-inflammatory properties and, therefore, should be considered as drug candidates for treating neuroinflammatory pathologies. When ingested, psilocybin is rapidly dephosphorylated to yield psilocin, which crosses the blood–brain barrier and exerts psychotropic activity by interacting with the 5-hydroxytryptamine 2A receptors (5-HT2ARs) on neurons. Since microglia express all three 5-HT2R isoforms, we hypothesized that, by interacting with these receptors, psilocin beneficially modulates select neuroimmune functions of microglia. We used microglia-like cell lines to demonstrate that psilocin, at non-toxic concentrations, did not affect the secretion of tumor necrosis factor (TNF) by immune-stimulated microglial cells, but significantly inhibited their phagocytic activity, the release of reactive oxygen species (ROS), and nitric oxide (NO) production. The inhibitory activity of psilocin on the latter two functions was similar to that of two selective 5-HT2R agonists, namely, 25I-NBOH and Ro60-0175. The role of this subfamily of receptors was further demonstrated by the application of 5-HT2R antagonists cyproheptadine and risperidone. Psilocin should be considered a novel drug candidate that might be effective in treating neuroimmune disorders, such as neurodegenerative diseases, where reactive microglia are significant contributors. |
|---|---|
| AbstractList | Neuroinflammation that is caused by microglia, the main immune cells of the brain, contributes to neurodegenerative diseases. Psychedelics, including psilocybin and lysergic acid diethylamide (LSD), possess certain anti-inflammatory properties and, therefore, should be considered as drug candidates for treating neuroinflammatory pathologies. When ingested, psilocybin is rapidly dephosphorylated to yield psilocin, which crosses the blood–brain barrier and exerts psychotropic activity by interacting with the 5-hydroxytryptamine 2A receptors (5-HT2ARs) on neurons. Since microglia express all three 5-HT2R isoforms, we hypothesized that, by interacting with these receptors, psilocin beneficially modulates select neuroimmune functions of microglia. We used microglia-like cell lines to demonstrate that psilocin, at non-toxic concentrations, did not affect the secretion of tumor necrosis factor (TNF) by immune-stimulated microglial cells, but significantly inhibited their phagocytic activity, the release of reactive oxygen species (ROS), and nitric oxide (NO) production. The inhibitory activity of psilocin on the latter two functions was similar to that of two selective 5-HT2R agonists, namely, 25I-NBOH and Ro60-0175. The role of this subfamily of receptors was further demonstrated by the application of 5-HT2R antagonists cyproheptadine and risperidone. Psilocin should be considered a novel drug candidate that might be effective in treating neuroimmune disorders, such as neurodegenerative diseases, where reactive microglia are significant contributors. Neuroinflammation that is caused by microglia, the main immune cells of the brain, contributes to neurodegenerative diseases. Psychedelics, including psilocybin and lysergic acid diethylamide (LSD), possess certain anti-inflammatory properties and, therefore, should be considered as drug candidates for treating neuroinflammatory pathologies. When ingested, psilocybin is rapidly dephosphorylated to yield psilocin, which crosses the blood–brain barrier and exerts psychotropic activity by interacting with the 5-hydroxytryptamine 2A receptors (5-HT 2A Rs) on neurons. Since microglia express all three 5-HT 2 R isoforms, we hypothesized that, by interacting with these receptors, psilocin beneficially modulates select neuroimmune functions of microglia. We used microglia-like cell lines to demonstrate that psilocin, at non-toxic concentrations, did not affect the secretion of tumor necrosis factor (TNF) by immune-stimulated microglial cells, but significantly inhibited their phagocytic activity, the release of reactive oxygen species (ROS), and nitric oxide (NO) production. The inhibitory activity of psilocin on the latter two functions was similar to that of two selective 5-HT 2 R agonists, namely, 25I-NBOH and Ro60-0175. The role of this subfamily of receptors was further demonstrated by the application of 5-HT 2 R antagonists cyproheptadine and risperidone. Psilocin should be considered a novel drug candidate that might be effective in treating neuroimmune disorders, such as neurodegenerative diseases, where reactive microglia are significant contributors. Neuroinflammation that is caused by microglia, the main immune cells of the brain, contributes to neurodegenerative diseases. Psychedelics, including psilocybin and lysergic acid diethylamide (LSD), possess certain anti-inflammatory properties and, therefore, should be considered as drug candidates for treating neuroinflammatory pathologies. When ingested, psilocybin is rapidly dephosphorylated to yield psilocin, which crosses the blood-brain barrier and exerts psychotropic activity by interacting with the 5-hydroxytryptamine 2A receptors (5-HT2ARs) on neurons. Since microglia express all three 5-HT2R isoforms, we hypothesized that, by interacting with these receptors, psilocin beneficially modulates select neuroimmune functions of microglia. We used microglia-like cell lines to demonstrate that psilocin, at non-toxic concentrations, did not affect the secretion of tumor necrosis factor (TNF) by immune-stimulated microglial cells, but significantly inhibited their phagocytic activity, the release of reactive oxygen species (ROS), and nitric oxide (NO) production. The inhibitory activity of psilocin on the latter two functions was similar to that of two selective 5-HT2R agonists, namely, 25I-NBOH and Ro60-0175. The role of this subfamily of receptors was further demonstrated by the application of 5-HT2R antagonists cyproheptadine and risperidone. Psilocin should be considered a novel drug candidate that might be effective in treating neuroimmune disorders, such as neurodegenerative diseases, where reactive microglia are significant contributors.Neuroinflammation that is caused by microglia, the main immune cells of the brain, contributes to neurodegenerative diseases. Psychedelics, including psilocybin and lysergic acid diethylamide (LSD), possess certain anti-inflammatory properties and, therefore, should be considered as drug candidates for treating neuroinflammatory pathologies. When ingested, psilocybin is rapidly dephosphorylated to yield psilocin, which crosses the blood-brain barrier and exerts psychotropic activity by interacting with the 5-hydroxytryptamine 2A receptors (5-HT2ARs) on neurons. Since microglia express all three 5-HT2R isoforms, we hypothesized that, by interacting with these receptors, psilocin beneficially modulates select neuroimmune functions of microglia. We used microglia-like cell lines to demonstrate that psilocin, at non-toxic concentrations, did not affect the secretion of tumor necrosis factor (TNF) by immune-stimulated microglial cells, but significantly inhibited their phagocytic activity, the release of reactive oxygen species (ROS), and nitric oxide (NO) production. The inhibitory activity of psilocin on the latter two functions was similar to that of two selective 5-HT2R agonists, namely, 25I-NBOH and Ro60-0175. The role of this subfamily of receptors was further demonstrated by the application of 5-HT2R antagonists cyproheptadine and risperidone. Psilocin should be considered a novel drug candidate that might be effective in treating neuroimmune disorders, such as neurodegenerative diseases, where reactive microglia are significant contributors. |
| Author | Lindhout, Ivan A Greuel, Bridget K Wiens, Kennedy R Klegeris, Andis Riar, Ishvin Brooks, Noah A H |
| AuthorAffiliation | Laboratory of Cellular and Molecular Pharmacology, Department of Biology, University of British Columbia Okanagan Campus, Kelowna, BC V1V 1V7, Canada |
| AuthorAffiliation_xml | – name: Laboratory of Cellular and Molecular Pharmacology, Department of Biology, University of British Columbia Okanagan Campus, Kelowna, BC V1V 1V7, Canada |
| Author_xml | – sequence: 1 givenname: Kennedy R. surname: Wiens fullname: Wiens, Kennedy R. – sequence: 2 givenname: Noah A. H. surname: Brooks fullname: Brooks, Noah A. H. – sequence: 3 givenname: Ishvin surname: Riar fullname: Riar, Ishvin – sequence: 4 givenname: Bridget K. orcidid: 0000-0002-8303-7743 surname: Greuel fullname: Greuel, Bridget K. – sequence: 5 givenname: Ivan A. surname: Lindhout fullname: Lindhout, Ivan A. – sequence: 6 givenname: Andis orcidid: 0000-0001-6587-6458 surname: Klegeris fullname: Klegeris, Andis |
| BookMark | eNplks9u1DAQxiNUJNrCA3CzxIUDKXbsJPUJoS2llbpQQTlbtjPe9cqxt7az0r4HD4zTrRAtJ__75jczn-ekOvLBQ1W9JfiMUo4_jsGBnhykhjekxefsRXVMWINrihk_-mf_qjpJaYNxQxhpj6vft8m6oK3_gPIa0G3a63WQOtsdoCVkqYKzGVAw6CDcq1m6DMPkZIaEfkLJm9E3mGKw4zh5QJeTL_HBpzlqaXUMK2elQwtwLiHrkURtfXXXoB-gYZtDrC9gC34An9FSeg_xdfXSSJfgzeN6Wv26_HK3uKpvvn-9Xny-qXXphNSG9T3DzGAYpJI9VURLwknPmGFUN0oZMD3HXV8cIYYUWyiojg4tL0epFD2trg_cIciN2EY7yrgXQVrxcBHiSsiYrXYgKB0M7zhuMSkZQZZ00CjGNQaD-5YW1qcDazupEQZduonSPYE-ffF2LVZhJ0pdrOcEF8L7R0IM9xOkLEabdDFNeghTEpQ05z3rSNMW6btn0k2Yoi9ezaqu1NixGUgOqvIFKUUwf6shWMxTI_6bGvoH2k-7Bw |
| Cites_doi | 10.1016/j.bbi.2011.12.002 10.1038/s41467-023-44016-1 10.1016/j.phrs.2016.08.007 10.1016/j.mcn.2020.103493 10.1111/ejn.14720 10.1056/NEJMoa2032994 10.1016/j.neuron.2007.01.008 10.1080/09540261.2018.1481827 10.1523/JNEUROSCI.1136-17.2017 10.1124/jpet.108.143461 10.1038/s41593-020-0687-6 10.3390/biomedicines8090331 10.1080/03602532.2016.1278228 10.3390/molecules28062624 10.1038/s41598-020-79328-5 10.3390/antiox12020517 10.3390/diseases10020030 10.1111/jnc.15327 10.1186/s13024-019-0333-5 10.1007/s12035-015-9355-3 10.1006/bcmd.2000.0298 10.1080/14728222.2019.1676416 10.1089/10799900050044769 10.1038/sj.bjp.0703510 10.1111/j.1699-0463.1995.tb01092.x 10.1016/j.pnpbp.2017.03.016 10.1007/BF02245606 10.1016/j.intimp.2024.111753 10.4049/jimmunol.145.8.2595 10.3390/antiox10030498 10.1038/s41429-020-0311-8 10.1016/j.bbi.2023.09.004 10.3389/ffgc.2022.813998 10.3389/fnagi.2018.00083 10.1101/2021.03.07.434103 10.1016/j.brainres.2023.148315 10.1016/S1474-4422(15)70016-5 10.1056/NEJMoa2206443 10.1038/s41386-019-0324-9 10.3390/antiox9080669 10.1124/mol.106.028720 10.3389/fpsyt.2023.1042440 10.4049/jimmunol.171.1.417 10.3390/psychoactives3010004 10.1016/j.freeradbiomed.2013.05.019 10.1016/j.addr.2007.11.005 10.1021/jm970030l 10.1007/BF03325217 10.1021/jm000339w 10.1007/s12035-019-01695-6 10.1074/jbc.M609426200 10.3233/JAD-141506 10.1021/acschemneuro.8b00637 10.3390/ijms222312899 10.1016/j.bbagen.2017.06.017 10.3390/cells9071717 10.1055/a-1686-9620 10.1038/s41577-023-00921-6 10.1016/j.euroneuro.2016.05.001 10.1007/s11419-017-0357-x 10.9758/cpn.23.1120 10.3390/biomedicines11041121 10.3389/fnins.2021.742065 10.1016/j.tips.2021.11.006 10.1155/2021/7086512 10.1016/j.pnpbp.2006.04.008 10.3390/brainsci14040328 10.1002/glia.22772 10.1523/JNEUROSCI.1860-14.2014 10.1016/j.euroneuro.2015.06.007 10.3390/antiox10091353 10.1007/s12035-013-8620-6 10.1556/2054.2022.00230 10.1111/jnc.15509 10.1006/bbrc.1996.0449 10.1016/j.yexcr.2014.04.018 10.1176/ajp.154.6.884a 10.1016/j.bcp.2017.09.008 10.1016/j.clinbiochem.2019.04.001 10.1155/2012/823902 10.1128/iai.65.10.4281-4287.1997 10.1016/j.intimp.2014.09.030 10.3389/fnins.2022.1039379 10.1074/jbc.275.15.11058 10.1074/jbc.M506172200 10.1016/S0028-3908(99)00010-6 10.1111/j.1476-5381.1996.tb15660.x 10.1101/pdb.prot095505 |
| ContentType | Journal Article |
| Copyright | 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2024 by the authors. 2024 |
| Copyright_xml | – notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2024 by the authors. 2024 |
| DBID | AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.3390/molecules29215084 |
| DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content (ProQuest) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry |
| EISSN | 1420-3049 |
| ExternalDocumentID | oai_doaj_org_article_33df969050104feaa73e2b49c0ef0753 10_3390_molecules29215084 |
| GrantInformation_xml | – fundername: Natural Sciences and Engineering Research Council of Canada – fundername: University of British Columbia Okanagan Campus – fundername: Jack Brown and Family Alzheimer’s Disease Research Foundation |
| GroupedDBID | --- 0R~ 123 2WC 3V. 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABJCF ABUWG ACGFO ACIWK ACPRK AEGXH AENEX AFKRA AFPKN AFRAH AFZYC AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 E3Z EBD EMOBN ESTFP ESX FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE HZ~ I09 IAO ITC KB. KQ8 LK8 M1P M7P MODMG M~E O-U O9- OK1 P2P PDBOC PIMPY PQQKQ PROAC PSQYO RIG RPM SV3 TR2 TUS UKHRP ~8M 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c3041-f477404f0edaba73b1ca191744f43c2bbfef790672151f11503eb63d5951fabb3 |
| IEDL.DBID | RPM |
| ISSN | 1420-3049 |
| IngestDate | Mon Nov 11 19:43:23 EST 2024 Mon Nov 11 05:42:11 EST 2024 Sat Nov 16 17:15:18 EST 2024 Fri Nov 08 20:46:18 EST 2024 Fri Nov 22 01:27:06 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 21 |
| Language | English |
| License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3041-f477404f0edaba73b1ca191744f43c2bbfef790672151f11503eb63d5951fabb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-8303-7743 0000-0001-6587-6458 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547910/ |
| PQID | 3126010640 |
| PQPubID | 2032355 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_33df969050104feaa73e2b49c0ef0753 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11547910 proquest_miscellaneous_3128746125 proquest_journals_3126010640 crossref_primary_10_3390_molecules29215084 |
| PublicationCentury | 2000 |
| PublicationDate | 20241028 |
| PublicationDateYYYYMMDD | 2024-10-28 |
| PublicationDate_xml | – month: 10 year: 2024 text: 20241028 day: 28 |
| PublicationDecade | 2020 |
| PublicationPlace | Basel |
| PublicationPlace_xml | – name: Basel |
| PublicationTitle | Molecules (Basel, Switzerland) |
| PublicationYear | 2024 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Ganguly (ref_6) 2021; 2021 Zhou (ref_52) 2016; 111 Koppula (ref_13) 2012; 2012 Pasqualetti (ref_10) 2009; 21 Leitner (ref_73) 2019; 23 Bos (ref_34) 1997; 40 ref_12 Arantes (ref_38) 2017; 35 DeTure (ref_3) 2019; 14 ref_55 Kapur (ref_79) 1997; 154 Kozlowska (ref_17) 2022; 162 ref_53 Wallach (ref_83) 2023; 14 ref_51 Chen (ref_61) 2014; 23 Larkin (ref_77) 2000; 20 Stempelj (ref_89) 2007; 282 Strawbridge (ref_20) 2015; 25 Yagami (ref_14) 2016; 53 Zhang (ref_60) 2014; 34 Heneka (ref_2) 2015; 14 Flanagan (ref_16) 2018; 30 Wang (ref_11) 2015; 44 Giribaldi (ref_30) 2021; 384 Rybka (ref_22) 2013; 63 Sato (ref_75) 2003; 171 Shah (ref_81) 2019; 10 Bernath (ref_45) 2023; 1807 ref_68 ref_23 ref_67 Faure (ref_74) 2000; 275 Kim (ref_21) 2006; 30 Galecki (ref_18) 2018; 80 Weisstaub (ref_29) 2007; 53 Martin (ref_39) 1998; 286 Brown (ref_66) 2024; 24 Madsen (ref_28) 2019; 44 ref_26 Watford (ref_58) 2024; 22 Braden (ref_35) 2006; 70 Laabi (ref_42) 2024; 130 Wenzel (ref_46) 2020; 105 Nichols (ref_57) 2020; 73 Anrather (ref_85) 2006; 281 Schotte (ref_80) 1996; 124 Fu (ref_64) 2014; 49 ref_72 Mason (ref_43) 2023; 114 ref_71 Crinelli (ref_15) 2000; 26 Belardelli (ref_78) 1995; 103 Butzlaff (ref_91) 2016; 2 Yu (ref_69) 2008; 327 Hughes (ref_49) 1997; 65 (ref_27) 2017; 49 Maura (ref_70) 2000; 130 Blair (ref_37) 2000; 43 ref_33 Hecker (ref_90) 1996; 118 ref_32 Cheshmehkani (ref_84) 2017; 146 Gojani (ref_88) 2024; 3 Butler (ref_5) 2021; 158 Goodwin (ref_31) 2022; 387 Simoncicova (ref_65) 2022; 43 Matsumoto (ref_76) 2008; 60 Barnes (ref_82) 1999; 38 Levy (ref_50) 1990; 145 Glebov (ref_59) 2015; 63 Nykamp (ref_25) 2022; 55 Kumar (ref_56) 2018; 2018 Rajendran (ref_62) 2018; 38 Troubat (ref_19) 2021; 53 Bove (ref_44) 2023; 6 ref_47 Brucato (ref_63) 2020; 20 Rickli (ref_36) 2016; 26 Kolyada (ref_86) 1996; 220 ref_41 Busche (ref_1) 2020; 23 Gouveia (ref_54) 2017; 1861 Gutierrez (ref_24) 2019; 56 ref_48 Zhu (ref_87) 2014; 327 ref_9 Krabbe (ref_40) 2012; 26 ref_4 Ozben (ref_8) 2019; 72 ref_7 |
| References_xml | – volume: 26 start-page: 419 year: 2012 ident: ref_40 article-title: Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2011.12.002 contributor: fullname: Krabbe – volume: 14 start-page: 8221 year: 2023 ident: ref_83 article-title: Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential publication-title: Nat. Commun. doi: 10.1038/s41467-023-44016-1 contributor: fullname: Wallach – volume: 111 start-page: 885 year: 2016 ident: ref_52 article-title: HNO suppresses LPS-induced inflammation in BV-2 microglial cells via inhibition of NF-ΚB and P38 MAPK pathways publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2016.08.007 contributor: fullname: Zhou – volume: 105 start-page: 103493 year: 2020 ident: ref_46 article-title: Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells publication-title: Mol. Cell. Neurosci. doi: 10.1016/j.mcn.2020.103493 contributor: fullname: Wenzel – volume: 53 start-page: 151 year: 2021 ident: ref_19 article-title: Neuroinflammation and depression: A review publication-title: Eur. J. Neurosci. doi: 10.1111/ejn.14720 contributor: fullname: Troubat – volume: 384 start-page: 1402 year: 2021 ident: ref_30 article-title: Trial of psilocybin versus escitalopram for depression publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2032994 contributor: fullname: Giribaldi – volume: 286 start-page: 913 year: 1998 ident: ref_39 article-title: 5-HT2C receptor agonists: Pharmacological characteristics and therapeutic potential publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Martin – volume: 53 start-page: 439 year: 2007 ident: ref_29 article-title: Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior publication-title: Neuron doi: 10.1016/j.neuron.2007.01.008 contributor: fullname: Weisstaub – volume: 30 start-page: 363 year: 2018 ident: ref_16 article-title: Psychedelics as anti-inflammatory agents publication-title: Int. Rev. Psychiatry doi: 10.1080/09540261.2018.1481827 contributor: fullname: Flanagan – volume: 38 start-page: 2911 year: 2018 ident: ref_62 article-title: Microglia-mediated synapse loss in Alzheimer’s disease publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1136-17.2017 contributor: fullname: Rajendran – volume: 327 start-page: 316 year: 2008 ident: ref_69 article-title: Serotonin 5-hydroxytryptamine2A receptor activation suppresses tumor necrosis factor-α-induced inflammation with extraordinary potency publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.108.143461 contributor: fullname: Yu – volume: 23 start-page: 1183 year: 2020 ident: ref_1 article-title: Synergy between amyloid-β and tau in Alzheimer’s disease publication-title: Nat. Neurosci. doi: 10.1038/s41593-020-0687-6 contributor: fullname: Busche – ident: ref_32 doi: 10.3390/biomedicines8090331 – volume: 49 start-page: 84 year: 2017 ident: ref_27 article-title: Metabolism of psilocybin and psilocin: Clinical and forensic toxicological relevance publication-title: Drug Metab. Rev. doi: 10.1080/03602532.2016.1278228 – ident: ref_33 doi: 10.3390/molecules28062624 – ident: ref_47 doi: 10.1038/s41598-020-79328-5 – ident: ref_72 doi: 10.3390/antiox12020517 – ident: ref_71 doi: 10.3390/diseases10020030 – volume: 158 start-page: 621 year: 2021 ident: ref_5 article-title: Microglial phagocytosis of neurons in neurodegeneration, and its regulation publication-title: J. Neurochem. doi: 10.1111/jnc.15327 contributor: fullname: Butler – volume: 14 start-page: 32 year: 2019 ident: ref_3 article-title: The neuropathological diagnosis of Alzheimer’s disease publication-title: Mol. Neurodegener. doi: 10.1186/s13024-019-0333-5 contributor: fullname: DeTure – volume: 53 start-page: 4754 year: 2016 ident: ref_14 article-title: Pathophysiological roles of cyclooxygenases and prostaglandins in the central nervous system publication-title: Mol. Neurobiol. doi: 10.1007/s12035-015-9355-3 contributor: fullname: Yagami – volume: 26 start-page: 211 year: 2000 ident: ref_15 article-title: Selective inhibition of NF-KB activation and TNF-α production in macrophages by red blood cell-mediated delivery of dexamethasone publication-title: Blood Cells Mol. Dis. doi: 10.1006/bcmd.2000.0298 contributor: fullname: Crinelli – volume: 23 start-page: 865 year: 2019 ident: ref_73 article-title: Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders publication-title: Expert Opin. Ther. Targets doi: 10.1080/14728222.2019.1676416 contributor: fullname: Leitner – volume: 20 start-page: 565 year: 2000 ident: ref_77 article-title: Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-γ receptor complex following activation by IFN-γ publication-title: J. Interferon Cytokine Res. doi: 10.1089/10799900050044769 contributor: fullname: Larkin – volume: 20 start-page: 1 year: 2020 ident: ref_63 article-title: Synaptic pruning in Alzheimer’s disease: Role of the complement system publication-title: Glob. J. Med. Res. contributor: fullname: Brucato – volume: 130 start-page: 1853 year: 2000 ident: ref_70 article-title: Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: Involvement of 5-HT 2C and 5-HT 1A receptors publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0703510 contributor: fullname: Maura – volume: 103 start-page: 161 year: 1995 ident: ref_78 article-title: Role of interferons and other cytokines in the regulation of the immune response publication-title: APMIS doi: 10.1111/j.1699-0463.1995.tb01092.x contributor: fullname: Belardelli – volume: 80 start-page: 291 year: 2018 ident: ref_18 article-title: The anti-inflammatory mechanism of antidepressants—SSRIs, SNRIs publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry doi: 10.1016/j.pnpbp.2017.03.016 contributor: fullname: Galecki – volume: 124 start-page: 57 year: 1996 ident: ref_80 article-title: Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding publication-title: Psychopharmacology doi: 10.1007/BF02245606 contributor: fullname: Schotte – volume: 130 start-page: 111753 year: 2024 ident: ref_42 article-title: Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2024.111753 contributor: fullname: Laabi – volume: 145 start-page: 2595 year: 1990 ident: ref_50 article-title: Induction of the respiratory burst in HL-60 cells. Correlation of Function and Protein Expression publication-title: J. Immunol. doi: 10.4049/jimmunol.145.8.2595 contributor: fullname: Levy – ident: ref_53 doi: 10.3390/antiox10030498 – volume: 73 start-page: 679 year: 2020 ident: ref_57 article-title: Psilocybin: From ancient magic to modern medicine publication-title: J. Antibiot. doi: 10.1038/s41429-020-0311-8 contributor: fullname: Nichols – volume: 114 start-page: 299 year: 2023 ident: ref_43 article-title: Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2023.09.004 contributor: fullname: Mason – ident: ref_26 doi: 10.3389/ffgc.2022.813998 – ident: ref_9 doi: 10.3389/fnagi.2018.00083 – ident: ref_41 doi: 10.1101/2021.03.07.434103 – volume: 1807 start-page: 148315 year: 2023 ident: ref_45 article-title: Microglia secrete distinct sets of neurotoxins in a stimulus-dependent manner publication-title: Brain Res. doi: 10.1016/j.brainres.2023.148315 contributor: fullname: Bernath – volume: 14 start-page: 388 year: 2015 ident: ref_2 article-title: Neuroinflammation in Alzheimer’s disease publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(15)70016-5 contributor: fullname: Heneka – volume: 387 start-page: 1637 year: 2022 ident: ref_31 article-title: Single-dose psilocybin for a treatment-resistant episode of major depression publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2206443 contributor: fullname: Goodwin – volume: 44 start-page: 1328 year: 2019 ident: ref_28 article-title: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels publication-title: Neuropsychopharmacology doi: 10.1038/s41386-019-0324-9 contributor: fullname: Madsen – ident: ref_12 doi: 10.3390/antiox9080669 – volume: 70 start-page: 1956 year: 2006 ident: ref_35 article-title: Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists publication-title: Mol. Pharmacol. doi: 10.1124/mol.106.028720 contributor: fullname: Braden – ident: ref_67 doi: 10.3389/fpsyt.2023.1042440 – volume: 171 start-page: 417 year: 2003 ident: ref_75 article-title: Direct binding of toll-like receptor 2 to zymosan, and zymosan-induced NF-κB zctivation and TNF-α secretion are down-regulated by lung collectin surfactant protein A publication-title: J. Immunol. doi: 10.4049/jimmunol.171.1.417 contributor: fullname: Sato – volume: 3 start-page: 48 year: 2024 ident: ref_88 article-title: The effects of psilocybin on lipopolysaccharide-induced inflammation in THP-1 human macrophages publication-title: Psychoactives doi: 10.3390/psychoactives3010004 contributor: fullname: Gojani – volume: 63 start-page: 187 year: 2013 ident: ref_22 article-title: Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2013.05.019 contributor: fullname: Rybka – volume: 60 start-page: 805 year: 2008 ident: ref_76 article-title: TLR3: Interferon induction by double-stranded RNA including Poly(I:C) publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2007.11.005 contributor: fullname: Matsumoto – volume: 40 start-page: 2762 year: 1997 ident: ref_34 article-title: Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(Indol-1-Yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-Yl)-1-methylethylamines: Improved therapeutics for obsessive compulsive disorder publication-title: J. Med. Chem. doi: 10.1021/jm970030l contributor: fullname: Bos – volume: 21 start-page: 102 year: 2009 ident: ref_10 article-title: A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer’s disease publication-title: Aging Clin. Exp. Res. doi: 10.1007/BF03325217 contributor: fullname: Pasqualetti – volume: 43 start-page: 4701 year: 2000 ident: ref_37 article-title: Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines publication-title: J. Med. Chem. doi: 10.1021/jm000339w contributor: fullname: Blair – volume: 56 start-page: 8628 year: 2019 ident: ref_24 article-title: Reboxetine treatment reduces neuroinflammation and neurodegeneration in the 5xFAD mouse model of Alzheimer’s disease: Role of CCL2 publication-title: Mol. Neurobiol. doi: 10.1007/s12035-019-01695-6 contributor: fullname: Gutierrez – volume: 282 start-page: 9797 year: 2007 ident: ref_89 article-title: Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate publication-title: J. Biol. Chem. doi: 10.1074/jbc.M609426200 contributor: fullname: Stempelj – volume: 44 start-page: 385 year: 2015 ident: ref_11 article-title: Anti-inflammatory drugs and risk of Alzheimer’s disease: An updated systematic review and meta-analysis publication-title: J. Alzheimer’s Dis. doi: 10.3233/JAD-141506 contributor: fullname: Wang – volume: 10 start-page: 2318 year: 2019 ident: ref_81 article-title: Revised pharmacophore model for 5-HT2A receptor antagonists derived from the atypical antipsychotic agent risperidone publication-title: ACS Chem. Neurosci. doi: 10.1021/acschemneuro.8b00637 contributor: fullname: Shah – ident: ref_55 doi: 10.3390/ijms222312899 – volume: 1861 start-page: 2274 year: 2017 ident: ref_54 article-title: Extracellular cytochrome c as an intercellular signaling molecule regulating microglial functions. Biochim. Biophys publication-title: Acta—Gen. Subj. doi: 10.1016/j.bbagen.2017.06.017 contributor: fullname: Gouveia – ident: ref_4 doi: 10.3390/cells9071717 – volume: 55 start-page: 24 year: 2022 ident: ref_25 article-title: Opportunities for drug repurposing of serotonin reuptake inhibitors: Potential uses in inflammation, infection, cancer, neuroprotection, and Alzheimer’s disease prevention publication-title: Pharmacopsychiatry doi: 10.1055/a-1686-9620 contributor: fullname: Nykamp – volume: 24 start-page: 91 year: 2024 ident: ref_66 article-title: Cell death by phagocytosis publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-023-00921-6 contributor: fullname: Brown – volume: 26 start-page: 1327 year: 2016 ident: ref_36 article-title: Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2016.05.001 contributor: fullname: Rickli – volume: 35 start-page: 408 year: 2017 ident: ref_38 article-title: 25I-NBOH: A new potent serotonin 5-HT2A receptor agonist identified in blotter paper seizures in Brazil publication-title: Forensic Toxicol. doi: 10.1007/s11419-017-0357-x contributor: fullname: Arantes – volume: 22 start-page: 2 year: 2024 ident: ref_58 article-title: Psilocybin, an effective treatment for major depressive disorder in adults—A systematic review publication-title: Clin. Psychopharmacol. Neurosci. doi: 10.9758/cpn.23.1120 contributor: fullname: Watford – ident: ref_51 doi: 10.3390/biomedicines11041121 – ident: ref_7 doi: 10.3389/fnins.2021.742065 – volume: 43 start-page: 669 year: 2022 ident: ref_65 article-title: Present and future of microglial pharmacology publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2021.11.006 contributor: fullname: Simoncicova – volume: 2021 start-page: 7086512 year: 2021 ident: ref_6 article-title: Oxidative stress, neuroinflammation, and NADPH oxidase: Implications in the pathogenesis and treatment of Alzheimer’s disease publication-title: Oxid. Med. Cell. Longev. doi: 10.1155/2021/7086512 contributor: fullname: Ganguly – volume: 30 start-page: 1091 year: 2006 ident: ref_21 article-title: Increased plasma nitric oxide level associated with suicide attempt in depressive patients publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry doi: 10.1016/j.pnpbp.2006.04.008 contributor: fullname: Kim – ident: ref_48 doi: 10.3390/brainsci14040328 – volume: 63 start-page: 626 year: 2015 ident: ref_59 article-title: Serotonin stimulates secretion of exosomes from microglia cells publication-title: Glia doi: 10.1002/glia.22772 contributor: fullname: Glebov – volume: 34 start-page: 11929 year: 2014 ident: ref_60 article-title: An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular vells of the cerebral cortex publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1860-14.2014 contributor: fullname: Zhang – volume: 25 start-page: 1532 year: 2015 ident: ref_20 article-title: Inflammation and clinical response to treatment in depression: A meta-analysis publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2015.06.007 contributor: fullname: Strawbridge – ident: ref_68 doi: 10.3390/antiox10091353 – volume: 49 start-page: 1422 year: 2014 ident: ref_64 article-title: Phagocytosis of microglia in the central nervous system diseases publication-title: Mol. Neurobiol. doi: 10.1007/s12035-013-8620-6 contributor: fullname: Fu – volume: 6 start-page: 171 year: 2023 ident: ref_44 article-title: Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum publication-title: J. Psychedelic Stud. doi: 10.1556/2054.2022.00230 contributor: fullname: Bove – volume: 162 start-page: 89 year: 2022 ident: ref_17 article-title: From Psychiatry to neurology: Psychedelics as prospective sherapeutics for neurodegenerative disorders publication-title: J. Neurochem. doi: 10.1111/jnc.15509 contributor: fullname: Kozlowska – volume: 220 start-page: 600 year: 1996 ident: ref_86 article-title: Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: Evidence for tissue specificity publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1996.0449 contributor: fullname: Kolyada – volume: 327 start-page: 256 year: 2014 ident: ref_87 article-title: The nuclear factor kappa B (NF-κB) activation is required for phagocytosis of Staphylococcus Aureus by RAW 264.7 cells publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2014.04.018 contributor: fullname: Zhu – volume: 154 start-page: 884 year: 1997 ident: ref_79 article-title: Cyproheptadine: A potent in vivo serotonin antagonist publication-title: Am. J. Psychiatry doi: 10.1176/ajp.154.6.884a contributor: fullname: Kapur – volume: 146 start-page: 139 year: 2017 ident: ref_84 article-title: Free-fatty acid receptor-4 (FFA4) modulates ROS generation and COX-2 expression via the C-terminal β-arrestin phosphosensor in RAW 264.7 macrophages publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2017.09.008 contributor: fullname: Cheshmehkani – volume: 2 start-page: 77 year: 2016 ident: ref_91 article-title: The role of serotonin receptors in Alzheimer’s disease publication-title: Opera Med. Physiol. contributor: fullname: Butzlaff – volume: 72 start-page: 87 year: 2019 ident: ref_8 article-title: Neuro-inflammation and anti-inflammatory treatment options for Alzheimer’s disease publication-title: Clin. Biochem. doi: 10.1016/j.clinbiochem.2019.04.001 contributor: fullname: Ozben – volume: 2012 start-page: 823902 year: 2012 ident: ref_13 article-title: Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson’s disease publication-title: Mediat. Inflamm. doi: 10.1155/2012/823902 contributor: fullname: Koppula – volume: 65 start-page: 4281 year: 1997 ident: ref_49 article-title: Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia Cepacia publication-title: Infect. Immun. doi: 10.1128/iai.65.10.4281-4287.1997 contributor: fullname: Hughes – volume: 23 start-page: 550 year: 2014 ident: ref_61 article-title: Regulation of neutrophil phagocytosis of Escherichia Coli by antipsychotic drugs publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2014.09.030 contributor: fullname: Chen – ident: ref_23 doi: 10.3389/fnins.2022.1039379 – volume: 275 start-page: 11058 year: 2000 ident: ref_74 article-title: Bacterial lipopolysaccharide activates NF-ΚB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.275.15.11058 contributor: fullname: Faure – volume: 281 start-page: 5657 year: 2006 ident: ref_85 article-title: NF-ΚB regulates phagocytic NADPH oxidase by inducing the expression of Gp91 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M506172200 contributor: fullname: Anrather – volume: 38 start-page: 1083 year: 1999 ident: ref_82 article-title: A review of central 5-HT receptors and their function publication-title: Neuropharmacology doi: 10.1016/S0028-3908(99)00010-6 contributor: fullname: Barnes – volume: 118 start-page: 2178 year: 1996 ident: ref_90 article-title: Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: Role of nuclear factor kB and interferon regulatory factor 1 publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.1996.tb15660.x contributor: fullname: Hecker – volume: 2018 start-page: pdb.prot095505 year: 2018 ident: ref_56 article-title: Analysis of cell viability by the MTT assay publication-title: Cold Spring Harb. Protoc. doi: 10.1101/pdb.prot095505 contributor: fullname: Kumar |
| SSID | ssj0021415 |
| Score | 2.4729838 |
| Snippet | Neuroinflammation that is caused by microglia, the main immune cells of the brain, contributes to neurodegenerative diseases. Psychedelics, including... |
| SourceID | doaj pubmedcentral proquest crossref |
| SourceType | Open Website Open Access Repository Aggregation Database |
| StartPage | 5084 |
| SubjectTerms | 5-hydroxytryptamine affective disorders Alzheimer's disease Anti-inflammatory agents Antidepressants Clinical trials Cytokines depression Drugs Ligands LSD Lysergic acid diethylamide Mental depression Neurodegeneration neurodegenerative diseases neuroprotection Nitric oxide phagocytic activity Serotonin Tumor necrosis factor-TNF |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB1BL3BBfIpAQUbihIia2M7XEbZd7WURUovELbKdMURaslWze-B_9Ad3xs6uiDhw4RpPpMQz9rynsd8AvC-V65wu8tSaqky117TmsCzTSqLzBWUI1Hw5eXVZfflen1-wTM6x1RefCYvywHHizpTqfEMUrmDi4NGYSqG0unEZekp3UeczKw9kaqJaOeWlWMNUROrPfsVWszjKRrIAup5loSDWP0OY8_ORfySc5WN4NCFF8Sl-4RO4h8NTeLA4NGh7Brdfx55SUT98FITiRNzKTNi_xBp35F2-Xyy2XkTD35ZN19uOO3bhKC5DCxwR5Dl6viaCYklZLgQiv7Xms3o_NhSgYoGbzSj6QRhRpKsrKQht4jXR9fR8aqK7E9xuGW-ew7flxdVilU5NFlKnMp2nXhMApJnNsDPkL2VzZ5jDafKbctJaj75quGBL2MAzflRoS9UVBM28sVa9gJNhO-BLEFWGhBeJcjpWkKkbUztih7YuMtcgmjKBD4dJb6-jlkZLHIQ91P7loQQ-s1uOhiyDHR5QcLRTcLT_Co4ETg9Obae1ObYql6G4rLME3h2HyXdcKjEDbvfBpq40o78E6lkwzD5oPjL0P4M-NyscVQTDXv2PX3gNDyXhKE6Xsj6Fk93NHt_A_bHbvw0hfweE0AnG priority: 102 providerName: Directory of Open Access Journals |
| Title | Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner |
| URI | https://www.proquest.com/docview/3126010640 https://www.proquest.com/docview/3128746125 https://pubmed.ncbi.nlm.nih.gov/PMC11547910 https://doaj.org/article/33df969050104feaa73e2b49c0ef0753 |
| Volume | 29 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELXYXuCCypcIlMpInBDpJrbzdYRtV3tZVKlF4hbZzrhE2k1Wm91D_wc_mBknqRr1xjWxJSsz9rwXz7xh7EsqbWVVEodGZ2monMI9B2kaZgKsSzBCgKLi5NVN9vN3fnlFMjnpWAvjk_atqS-azfaiqf_43Mrd1s7HPLH59XpBEjIZxrn5jM0QHI4cfaBZMcak_v5SIqGfb_s2s9CJQpD4uZpEIC_UP0GX09zIR8FmecpeDiiRf-9X84o9g-Y1e74Ym7O9YX-vuxrDUN1844jgeH-MaX928TUc0LJUW8xbx_uB94aGrtuKunVBx298-xvupTlqKhEBvsQI552QZq0pT-9ug87JF7DZdLxuuOZJuLoVHJEm7JCqh5dDA90Dp1bLsH_Lfi2vbhercGiwEFoZqTh0CsFfpFwElUZbSRNbTfxNoc2kFcY4cFlBl7WICxxhRwkmlVWCsMxpY-Q7dtK0DbxnPIsAsSLSTUvqMXmhc4vM0ORJZAsAnQbs6_jRy12vo1Ei_yALlU8sFLAfZJaHgSSB7R-0-7tycAScWrkCuX1CjNKBxvWDMKqwETjEQTJgZ6NRy2FfdqWMhb9YVlHAPj-8RtvRNYluoD36MXmmCPkFLJ84w2RB0zfoql6be3TND_8_9SN7IRA5UYAU-Rk7OeyP8InNuup47v8YnHt3_weKJAoz |
| link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELVoOZQL34jQAkbihEjXiZ2vI2y7WkS3qtRF4hbFzriNtJusNrsH_kd_MDNOUhFx6zW2JUszk3lPM37D2OdYmtKoKPB1kcS-sgpjDuLYT0IwNsIMAYoeJ8-vk8vf6dk5yeTEw1sY17RvdHVar9andXXreis3azMZ-sQmV4spScgkmOcmB-wxBqwQA0vviVaAWamrYEqk9JN1N2gW2jALSf5cjXKQk-of4ctxd-Q_6Wb27KEXfc6e9gCTf-vWX7BHUL9kR9NhrtsrdnfVVpjBqvorR_DHuz9g4X57fAE7dAp6lswby7uNfzRtXTQlDfqCll-7yTncqXpU9LoE-AyTo_NfOrWgFr-bFfo1n8Jq1fKq5gWP_Pky5AhSYYMs3z_rZ-_uOE1phu1r9mt2vpzO_X42g2-kUIFvFeJGoayAskAzSx2YgqifQnNLE2ptwSYZ1XkRUliCnRJ0LMsIEZ0ttJZv2GHd1PCW8UQAwkxkqoaEZ9KsSA2SSp1GwmQAReyxL4O18k0nwZEjdSHT5v-Z1mPfyZ73G0k9231otjd5bxo8WtoszkREZNRCgfeHUKvMCLAIoaTHTgZvyPuQbnMZhK4mrYTHPt0vo-2owlLU0OzdnjRRBBo9lo68aHSh8Qo6j5P1Hpzl3cOPfmRH8-XiIr_4cfnzmD0JEYBRng3TE3a42-7hPTtoy_0HFy1_AadiHvM |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nj9MwELXYRQIufK8ILGAkTohsEtv54gbtVkXQVaVdJG5R7IyXSG1aNe2B_8EPZsZJVkTc4JqMJUsz43lPHr9h7G0iTWVUHPm6TBNfWYU5B0nipwKMjbFCgKLHyfPL9OJ7Nj0nmZwPw1sY17RvdH3WrNZnTf3D9VZu1yYY-sSC5WJCEjIp1rlgW9ngiN3GpA3FwNR7shVhZepuMSXS-mDdDZuFVuSCJNDVqA45uf4Rxhx3SP5RcmYP_mezD9n9Hmjyj53NI3YLmsfs7mSY7_aE_Vq2NVayunnPEQTy7iQs3fHHF7DH4KDnyXxjeWf4U5PpYlPRwC9o-aWboMOdukdNr0yAz7BIujimVQtq9bteYXzzCaxWLa8bXvLYn18JjmAVtsj2_Wk_g3fPaVoz7J6yb7Pzq8nc72c0-EaGKvKtQvwYKhtCVaK7pY5MSRRQodulEVpbsGlO970ILSzBTwk6kVWMyM6WWssTdtxsGnjGeBoCwk1krIYEaLK8zAySS53FockBysRj7waPFdtOiqNACkPuLf5yr8c-kU9vDElF233Y7K6L3j24tLJ5kocxkVILJe4fhFa5CcEilJIeOx0iouhTuy1kJNzdtAo99ubmN_qOblrKBjYHZ5OlisCjx7JRJI02NP6DAeTkvYeAef7vS1-zO8vprPj6-eLLC3ZPIA6jciuyU3a83x3gJTtqq8MrlzC_AYnoIXM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psilocin%2C+the+Psychoactive+Metabolite+of+Psilocybin%2C+Modulates+Select+Neuroimmune+Functions+of+Microglial+Cells+in+a+5-HT2+Receptor-Dependent+Manner&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Wiens%2C+Kennedy+R&rft.au=Brooks%2C+Noah+A+H&rft.au=Riar%2C+Ishvin&rft.au=Greuel%2C+Bridget+K&rft.date=2024-10-28&rft.pub=MDPI+AG&rft.eissn=1420-3049&rft.volume=29&rft.issue=21&rft.spage=5084&rft_id=info:doi/10.3390%2Fmolecules29215084&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon |